Plain-English translation of NCT06613854 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study compares two different combination approaches to treating type 2 diabetes early on. You would take metformin (a standard diabetes medication) plus either or empagliflozin—two newer medications known to help blood sugar control and protect the heart. The goal is to see which combination works best and keeps your blood sugar stable over 26 weeks.
Type 2 diabetes can damage your heart and blood vessels over time. Recent guidelines suggest that starting two medications together from the beginning—rather than adding them one at a time—may help you reach safe blood sugar levels faster and prevent complications. However, doctors don't yet know which two-medication combination is best to use first.
You likely qualify if…
You likely don't qualify if…
You would visit the study center regularly over 26 weeks (about 6 months). You would take your assigned medication combination—either metformin plus one of the two new treatments—and follow the dosing schedule provided. The study team would check your blood sugar, take blood tests, and may use a continuous glucose monitor (a small device that tracks your blood sugar throughout the day) to see how well the treatment is working.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Slovenia